|
AREDS2 DNA Detail
|
|
|
| Records Return:
(445)
|
|
|
|
| dbGaP Submitter Subject ID (ID2) | Coriell Sample ID | Consent | Control | Gender | Race | Age | Baseline Max AMD Severity | Final Max AMD Severity |
| AR2_0029 | ED148070 | General Research Use | No | Female | White | 70 | 7 - AREDS AMD Severity Scale Step 7 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0224 | ED148870 | General Research Use | No | Male | White | 72 | 4 - AREDS AMD Severity Scale Step 4 | 6 - AREDS AMD Severity Scale Step 6 |
| AR2_0437 | ED149905 | General Research Use | No | Male | White | 71 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_0757 | ED148835 | General Research Use | No | Female | White | 73 | 6 - AREDS AMD Severity Scale Step 5 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0898 | ED148650 | General Research Use | No | Male | White | 73 | 7 - AREDS AMD Severity Scale Step 7 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_1041 | ED149931 | General Research Use | No | Male | White | 74 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_1316 | ED149147 | General Research Use | No | Female | White | 72 | 7 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_1410 | ED149438 | General Research Use | No | Male | White | 74 | 4 - AREDS AMD Severity Scale Step 4 | 6 - AREDS AMD Severity Scale Step 6 |
| AR2_1440 | ED148236 | General Research Use | No | Female | White | 74 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_1452 | ED148889 | General Research Use | No | Female | White | 74 | 7 - AREDS AMD Severity Scale Step 7 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_1759 | ED148588 | General Research Use | No | Female | White | 70 | 3 - AREDS AMD Severity Scale Step 1 | 6 - AREDS AMD Severity Scale Step 6 |
| AR2_2275 | ED148442 | General Research Use | No | Female | White | 70 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue | 10 - Central GA |
| AR2_2500 | ED149855 | General Research Use | No | Female | White | 72 | 9 - AREDS AMD Severity Scale Step 9 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_2544 | ED148124 | General Research Use | No | Female | White | 71 | 8 - AREDS AMD Severity Scale Step 8 | 10 - Central GA |
| AR2_2721 | ED148949 | General Research Use | No | Male | White | 71 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_2799 | ED148768 | General Research Use | No | Female | White | 70 | 10 - Central GA | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_3057 | ED149392 | General Research Use | No | Male | White | 70 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_3109 | ED148538 | General Research Use | No | Male | White | 73 | 7 - AREDS AMD Severity Scale Step 7 | 9 - AREDS AMD Severity Scale Step 9 |
| AR2_3448 | ED148565 | General Research Use | No | Female | White | 71 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_3545 | ED149503 | General Research Use | No | Male | White | 70 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
|
|
|
|